Human SNP ID | rs4783227 |
---|---|
Human chromosome | chr16 |
Human SNP position | 82560778 |
Pig chromosome | chr6 |
Pig SNP position | 6418155 |
PubMed ID | 20195266 |
---|---|
Journal | Mol Psychiatry |
Link | www.ncbi.nlm.nih.gov/pubmed/20195266 |
Study | Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. |
Disease/Trait | Response to antipsychotic treatment |
Initial sample | 421 European ancestry, 214 African American, and 103 cases |
Replication sample | NA |
Region | 16q23.3 |
Chromosome id | chr16 |
Chromosome position | 82560778 |
Reported gene | intergenic |
Mapped gene | LOC101928392 |
Upstream gene id | |
Downstream gene id | |
SNP gene ids | 101928392 |
Upstream gene distance | |
Downstream gene distance | |
SNP risk allele | rs4783227-? |
SNPs | rs4783227 |
Merged | 0 |
SNP id current | 4783227 |
Context | intron_variant |
Intergenic | 0 |
Allele frequency | 0.424 |
P value | 0.0000004 |
Pvalue mlog | 6.39794000867203 |
P value text | (olanzapine-total cholesterol) |
Or beta | |
%95 Ci | |
Platform | Affymetrix [492900] |
CNV | N |
Mapped trait | response to olanzapine |
Mapped trait URI | http://purl.obolibrary.org/obo/GO_0097333 |
Study accession | GCST000618 |